Document Detail


Cost-effectiveness of hybrid PET/CT for staging of non-small cell lung cancer.
MedLine Citation:
PMID:  21051648     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
METHODS: The study is based on 172 NSCLC patients from a prospective clinical study who underwent diagnostic, contrast-enhanced helical CT and integrated PET/CT. Imaging was performed at the University Hospital Ulm between May 2002 and December 2004. To calculate treatment costs, we differentiated among cost for diagnosis, cost for nonsurgical treatment according to the clinical diagnosis, and cost for surgical procedures according to the clinical tumor stage.
RESULTS: The diagnostic effectiveness in terms of correct TNM staging was 40% (31/77) for CT alone and 60% (46/77) for PET/CT. For the assessment of resectability (tumor stages Ia-IIIa vs. IIIb-IV), 65 of 77 patients (84%) were staged correctly by PET/CT (CT alone, 70% [54/77]). The incremental cost-effectiveness ratios per correctly staged patient were $3,508 for PET/CT versus CT alone. The incremental cost-effectiveness ratios per quality-adjusted life year gained were $79,878 for PET/CT vs. CT alone, decreasing to $69,563 assuming a reduced loss of utility (0.10 quality-adjusted life years) due to surgical morbidity.
CONCLUSION: Cost-effectiveness analyses showed that costs for PET/CT are within the commonly accepted range for diagnostic tests or therapies. Therefore, reimbursement of PET/CT for NSCLC staging can be also recommended from an economic point of view.
Authors:
Jonas Schreyögg; Julia Weller; Tom Stargardt; Ken Herrmann; Christina Bluemel; Tobias Dechow; Gerhard Glatting; Bernd J Krause; Felix Mottaghy; Sven N Reske; Andreas K Buck
Related Documents :
18377828 - The role of pet-ct in the management of patients with advanced cancer of the head and n...
17537758 - Fdg-pet/ct in restaging of patients with recurrent breast cancer: possible impact on st...
6284468 - Utility of diagnostic imaging in the staging of gestational trophoblastic disease.
18767178 - Accuracy of 18f-fdg-pet/ct for staging of oral squamous cell carcinoma.
11957448 - Exploring frameless stereotactic image guided surgery.
10353108 - Quantitation of iodine-123-beta-cit dopamine receptor uptake in a phantom model.
Publication Detail:
Type:  Clinical Trial; Journal Article    
Journal Detail:
Title:  Journal of nuclear medicine : official publication, Society of Nuclear Medicine     Volume:  51     ISSN:  1535-5667     ISO Abbreviation:  J. Nucl. Med.     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-11-05     Completed Date:  2010-12-15     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0217410     Medline TA:  J Nucl Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1668-75     Citation Subset:  IM    
Affiliation:
Institute of Health Economics and Health Care Management, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany. schreyoegg@bwl.lmu.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Carcinoma, Non-Small-Cell Lung / economics*,  pathology*,  radiography,  radionuclide imaging
Cost-Benefit Analysis
Decision Making
Female
Humans
Insurance, Health, Reimbursement / economics
Lung Neoplasms / economics*,  pathology*,  radiography,  radionuclide imaging
Male
Middle Aged
Neoplasm Staging / economics*
Positron-Emission Tomography / economics*
Proportional Hazards Models
Quality-Adjusted Life Years
Sensitivity and Specificity
Tomography, X-Ray Computed / economics*
Comments/Corrections
Comment In:
J Nucl Med. 2010 Nov;51(11):1665-7   [PMID:  20956473 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Functional compartmentalization and viewpoint generalization within the macaque face-processing syst...
Next Document:  Voxel-based analysis of asymmetry index maps increases the specificity of 18F-MPPF PET abnormalities...